Baihua Pharmaceutical announced that the controlling shareholder and actual controller of the company is planning the transfer of the company's share agreement. This matter may lead to a change in the company's control. In order to ensure fair disclosure of information, protect investors' interests, and avoid causing abnormal fluctuations in the company's stock price, trading of the company's shares will continue to be suspended from the opening of the market on December 31, 2025. It is expected that trading will continue to be suspended for no more than 3 trading days.

Baihua Pharmaceutical announced that the controlling shareholder and actual controller of the company is planning the transfer of the company's share agreement. This matter may lead to a change in the company's control. In order to ensure fair disclosure of information, protect investors' interests, and avoid causing abnormal fluctuations in the company's stock price, trading of the company's shares will continue to be suspended from the opening of the market on December 31, 2025. It is expected that trading will continue to be suspended for no more than 3 trading days.